Medtronic had its Relative Strength (RS) Rating upgraded from 79 to 84 Tuesday.
This unique rating identifies technical performance by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks matches up against the rest of the market.
Over 100 years of market history reveals that the market's biggest winners typically have an 80 or better RS Rating in the early stages of their moves.
Risk Management In The Stock Market: How Much Money To Invest Now
While the stock is not near an ideal buying range right now, see if it is able to form and break out of a proper base.
Earnings growth rose last quarter from 1% to 7%. But revenue gains fell from 5% to 3%.
Medtronic earns the No. 21 rank among its peers in the Medical-Products industry group. Boston Scientific, Pro-Dex and Axogen are among the top 5 highly rated stocks within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
